Literature DB >> 33477970

Unlike Its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell Survival.

Siska Van Belle1, Sara El Ashkar1, Kateřina Čermáková2, Filip Matthijssens3,4, Steven Goossens4,5, Alessandro Canella1, Courtney H Hodges6, Frauke Christ1, Jan De Rijck1, Pieter Van Vlierberghe3,4, Václav Veverka2,7, Zeger Debyser1.   

Abstract

HDGF-related protein 2 (HRP-2) is a member of the Hepatoma-Derived Growth Factor-related protein family that harbors the structured PWWP and Integrase Binding Domain, known to associate with methylated histone tails or cellular and viral proteins, respectively. Interestingly, HRP-2 is a paralog of Lens Epithelium Derived Growth Factor p75 (LEDGF/p75), which is essential for MLL-rearranged (MLL-r) leukemia but dispensable for hematopoiesis. Sequel to these findings, we investigated the role of HRP-2 in hematopoiesis and MLL-r leukemia. Protein interactions were investigated by co-immunoprecipitation and validated using recombinant proteins in NMR. A systemic knockout mouse model was used to study normal hematopoiesis and MLL-ENL transformation upon the different HRP-2 genotypes. The role of HRP-2 in MLL-r and other leukemic, human cell lines was evaluated by lentiviral-mediated miRNA targeting HRP-2. We demonstrate that MLL and HRP-2 interact through a conserved interface, although this interaction proved less dependent on menin than the MLL-LEDGF/p75 interaction. The systemic HRP-2 knockout mice only revealed an increase in neutrophils in the peripheral blood, whereas the depletion of HRP-2 in leukemic cell lines and transformed primary murine cells resulted in reduced colony formation independently of MLL-rearrangements. In contrast, primary murine HRP-2 knockout cells were efficiently transformed by the MLL-ENL fusion, indicating that HRP-2, unlike LEDGF/p75, is dispensable for the transformation of MLL-ENL leukemogenesis but important for leukemic cell survival.

Entities:  

Keywords:  animal model; cell culture; cell proliferation; hematopoietic stem cell; leukemia; molecular cell biology; nuclear magnetic resonance (NMR); protein complex; protein-protein interaction

Year:  2021        PMID: 33477970      PMCID: PMC7835958          DOI: 10.3390/cells10010192

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  65 in total

1.  PSIP1/p75 promotes tumorigenicity in breast cancer cells by promoting the transcription of cell cycle genes.

Authors:  Deepak K Singh; Omid Gholamalamdari; Mahdieh Jadaliha; Xiao Ling Li; Yo-Chuen Lin; Yang Zhang; Shuomeng Guang; Seyedsasan Hashemikhabir; Saumya Tiwari; Yuelin J Zhu; Abid Khan; Anu Thomas; Arindam Chakraborty; Virgilia Macias; Andre K Balla; Rohit Bhargava; Sarath Chandra Janga; Jian Ma; Supriya G Prasanth; Ashish Lal; Kannanganattu V Prasanth
Journal:  Carcinogenesis       Date:  2017-10-01       Impact factor: 4.944

2.  Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

Authors:  Akihiko Yokoyama; Michael L Cleary
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

3.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

4.  Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations.

Authors:  Heidi G Sutherland; Kathryn Newton; David G Brownstein; Megan C Holmes; Clémence Kress; Colin A Semple; Wendy A Bickmore
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

5.  Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein-Protein Interaction.

Authors:  Angelo Aguilar; Ke Zheng; Tianfeng Xu; Shilin Xu; Liyue Huang; Ester Fernandez-Salas; Liu Liu; Denzil Bernard; Kaitlin P Harvey; Caroline Foster; Donna McEachern; Jeanne Stuckey; Krishnapriya Chinnaswamy; James Delproposto; Jeff W Kampf; Shaomeng Wang
Journal:  J Med Chem       Date:  2019-06-22       Impact factor: 7.446

6.  Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C.

Authors:  Stav Sapoznik; Batya Cohen; Yael Tzuman; Gila Meir; Shifra Ben-Dor; Alon Harmelin; Michal Neeman
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

7.  Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75).

Authors:  H Méreau; J De Rijck; K Cermáková; A Kutz; S Juge; J Demeulemeester; R Gijsbers; F Christ; Z Debyser; J Schwaller
Journal:  Leukemia       Date:  2013-01-15       Impact factor: 11.528

8.  LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells.

Authors:  Goedele Maertens; Peter Cherepanov; Wim Pluymers; Katrien Busschots; Erik De Clercq; Zeger Debyser; Yves Engelborghs
Journal:  J Biol Chem       Date:  2003-06-09       Impact factor: 5.157

9.  Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.

Authors:  Subhalakshmi Sharma; Kateřina Čermáková; Jan De Rijck; Jonas Demeulemeester; Milan Fábry; Sara El Ashkar; Siska Van Belle; Martin Lepšík; Petr Tesina; Vojtěch Duchoslav; Petr Novák; Martin Hubálek; Pavel Srb; Frauke Christ; Pavlína Řezáčová; H Courtney Hodges; Zeger Debyser; Václav Veverka
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-11       Impact factor: 11.205

10.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

View more
  1 in total

1.  The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells.

Authors:  Greisha L Ortiz-Hernandez; Evelyn S Sanchez-Hernandez; Pedro T Ochoa; Catherine C Elix; Hossam R Alkashgari; James R W McMullen; Ubaldo Soto; Shannalee R Martinez; Carlos J Diaz Osterman; Michael Mahler; Sourav Roy; Carlos A Casiano
Journal:  Cells       Date:  2021-10-12       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.